Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
Clinical trial NCT03626714 · COMPLETED
Trial details
- NCT number
- NCT03626714
- Sponsor
- Auritec Pharmaceuticals
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2019-01-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.